VHCP Management EG, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 198,258 shares at $12.55 ($2.5M) on 2024-01-22, disclosed to the SEC on 2024-01-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.55 | 67,546 | $848K | 34.1% |
| 2 | $12.55 | 67,546 | $848K | 34.1% |
| 3 | $12.54 | 10,897 | $137K | 5.5% |
| 4 | $12.54 | 10,897 | $137K | 5.5% |
| 5 | $12.44 | 20,686 | $257K | 10.4% |
| 6 | $12.44 | 20,686 |
| $257K |
| 10.4% |
| Total | $12.53 avg | 198,258 | $2.5M | 100% |
| Filing → |